The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of chemotherapy induced neutropenia at 1-month mark (CIN-1-month) and overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: A Cohort study.
 
Pashtoon Murtaza Kasi
No Relationships to Disclose
 
Daisuke Kotani
No Relationships to Disclose
 
Michael Cecchini
No Relationships to Disclose
 
Kohei Shitara
Consulting or Advisory Role - Bayer; Chugai Pharma; Lilly; Takeda
Research Funding - Bayer; Chugai Pharma; Daiichi Sankyo; Dainippon Sumitomo Pharma; Lilly; MSD; Sanofi; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Atsushi Ohtsu
Employment - Celgene (I)
Research Funding - Bristol-Myers Squibb
 
Ramesh K. Ramanathan
Honoraria - Celgene; Cerulean Pharma; Lilly; Pharmacyclics; Taiho Pharmaceutical; Vaccinex
Consulting or Advisory Role - Celgene; Genentech; Lilly; Vaccinex
Research Funding - Abbvie; Bayer; Biomarin; Celgene; Genentech; Halozyme; Merck/Schering Plough; Merrimack; Sanofi; Tekmira; Vaccinex; Verastem
Travel, Accommodations, Expenses - Biomarin
Other Relationship - Celgene
 
Howard S. Hochster
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Sirtex Medical
Speakers' Bureau - Genomic Health
 
Axel Grothey
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche
 
Takayuki Yoshino
Research Funding - Sumitomo Dainippon